According to the latest status from November 2024, Invex Therapeutics paid a total of 0.19 AUD per share in dividends within the last 12 months. With the current Invex Therapeutics price of 0.09 AUD, this corresponds to a dividend yield of 207 %. A dividend is paid times per year.
| 207 % Dividend Yield | = |
|
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|---|
| 1/8/2024 | 0.19 |
3 years
5 years
10 years
25 Years
Max
The dividend per year chart for Invex Therapeutics provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Invex Therapeutics’s potential for long-term investment and income generation through dividends.
Incorporate the dividend data in evaluating Invex Therapeutics's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
| Date | Invex Therapeutics Dividend |
|---|---|
| 2023 | 0.19 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2018 | 0 AUD | 0 AUD |
| 2019 | 0 AUD | 0 AUD |
| 2020 | 0 AUD | 0 AUD |
| 2021 | 0 AUD | 0 AUD |
| 2022 | 0 AUD | 0 AUD |
| 2023 | 0.19 AUD | 0 AUD |
| 2024 | 0 AUD | 0 AUD |
Invex Therapeutics has been increasing the dividend for 1 years.
Over the past 7 years, Invex Therapeutics has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Invex Therapeutics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Examining Invex Therapeutics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Invex Therapeutics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Changes in Invex Therapeutics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Over the past 12 months, Invex Therapeutics paid a dividend of 0.19 AUD . This corresponds to a dividend yield of about 207 %. For the coming 12 months, Invex Therapeutics is expected to pay a dividend of 0.19 AUD.
The current dividend yield of Invex Therapeutics is 207 %.
Invex Therapeutics pays a quarterly dividend. This is distributed in the months of .
Invex Therapeutics paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0.19 AUD are expected. This corresponds to a dividend yield of 207 %.
Invex Therapeutics is assigned to the 'Health' sector.
To receive the latest dividend of Invex Therapeutics from 12/18/2023 amounting to 0.186 AUD, you needed to have the stock in your portfolio before the ex-date on 12/8/2023.
The last dividend was paid out on 12/18/2023.
In the year 2023, Invex Therapeutics distributed 0 AUD as dividends.
The dividends of Invex Therapeutics are distributed in AUD.
Our stock analysis for Invex Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Invex Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.